Meitu, a Hong Kong stock company, rose more than 10% in intraday trading, with turnover exceeding HK$ 400 million.Shanghai Nickel's main contract has expanded, and now it has risen by more than 3% to 129,170 yuan/ton.China's assets ETF and China Stock Exchange rose by nearly 5% when they were rich, China's assets ETF and China Stock Exchange rose by nearly 5% when they were rich, and China's ETF rose by nearly 5% when they were rich three times. China's overseas Internet ETF rose by nearly 2%; Bili Bili rose nearly 4%, Xpeng Motors rose nearly 3%, Pinduoduo and Baidu rose over 2%, and Ali and Weilai rose nearly 2%.
The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.OPEC continues to lower its global oil demand forecast. According to Xinhua News Agency, the Organization of Petroleum Exporting Countries (OPEC) released its monthly oil market report on the 11th, lowering its global oil demand forecast for 2024 and 2025. This is the fifth time that OPEC has lowered its global oil demand forecast for this year and next since August this year.Market News: Mossad leaders visited Doha, Qatar, on Wednesday to hold a Gaza negotiation meeting with Qatar's Prime Minister.
The concept of robots has partially returned, and the Wuzhou New Year, Yuanda Intelligent daily limit, Great Wheel Intelligence, Mingke Jingji, Astar, Fengli Intelligent, Sanfeng Intelligent, etc. have followed suit.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.The Hang Seng Index rose more than 1%, the Hang Seng Technology Index rose 1.47%, and the technology stocks strengthened.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
12-13
Strategy guide
12-13